13 completed, 1 withdrawn. 14 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Completed 13, Withdrawn 1 |
Follow Mycophenolate Sodium: new trials by email Literature Review of Mycophenolate Sodium trials Research Report on Mycophenolate Sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation Sirolimus, Everolimus, Mycophenolic acid - Kidney Transplant Infection | Phase 4 | Completed | Hospital do Rim e Hipertensão | 1209 | 2017-06-18 | 2023-04-24 |
| Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients Tacrolimus Extended Release Capsule, Mycophenolate mofetil, Prednisone - Immunosuppression | Phase 4 | Completed | Medical University of South Carolina | 25 | 2017-05-05 | 2019-12-26 |
| Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring Myfortic®, Neoral®, Cellcept® - Cardiovascular Disease, Cardiovascular Outcomes | Phase 4 | Withdrawn | University of Saskatchewan | 2014-02-01 | 2017-01-09 | |
| Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients sirolimus, tacrolimus, mycophenolate - Disorder Related to Renal Transplantation, Cytomegalovirus Infections | Phase 4 | Completed | Associação Médico Espírita de Botucatu | 48 | 2014-01-01 | 2016-02-17 |
| A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) Mycophenolate sodium, Mycophenolate mofetil - Renal Transplantation | Phase 4 | Completed | Irmandade Santa Casa de Misericórdia de Porto Alegre | 100 | 2013-04-01 | 2015-04-03 |
| Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS Mycophenolate sodium, Pantoprazole, Mycophenolate mofetil - Transplantation, Immunosuppression | Phase 4 | Completed | Klemens Budde | 20 | 2012-01-01 | 2019-02-21 |
| Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate Thymoglobulin, Everolimus, Basiliximabe - Cytomegalovirus Infection, Renal Transplant Failure | Phase 4 | Completed | Hospital do Rim e Hipertensão | 300 | 2011-05-01 | 2015-03-23 |
| Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation Basiliximab, Tacrolimus, Mycophenolic Acid - Liver Transplantation | Phase 4 | Completed | University of California, Los Angeles | 59 | 2011-01-01 | 2022-09-29 |
| Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study Myfortic plus low-dose steroid, Prednisolone - Nephrosis, Lipoid | Phase 4 | Completed | The University of Hong Kong | 20 | 2010-09-01 | 2018-06-01 |
| A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients MMF, EC-MPS, Prednisone - Kidney Transplantation | Phase 4 | Completed | Hoffmann-La Roche | 23 | 2009-11-01 | 2015-08-27 |
| A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients Prograf, Advagraf, Myfortic - Liver Transplantation | Phase 4 | Completed | Astellas Pharma Inc | 44 | 2009-04-01 | 2016-01-29 |
| Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant Mycophenolate sodium - Kidney Transplantation | Phase 4 | Completed | Novartis | 18 | 2008-05-01 | 2017-02-23 |
| Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State Myfortic - Kidney Transplantation | Phase 4 | Completed | University of Utah | 21 | 2007-12-01 | 2016-05-06 |
| Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients Mycophenolate Sodium - Gastrointestinal Symptoms, Heart Transplantation | Phase 4 | Completed | Cedars-Sinai Medical Center | 11 | 2006-06-01 | 2020-07-30 |
Cytomegalovirus Infections (2) · Cardiovascular Diseases (1) · Nephrosis, Lipoid (1) · Rejection, Psychology (1) · Renal Insufficiency (1)
Hospital do Rim e Hipertensão (2) · Associação Médico Espírita de Botucatu (1) · Astellas Pharma Inc (1) · Cedars-Sinai Medical Center (1) · Hoffmann-La Roche (1) · Irmandade Santa Casa de Misericórdia de Porto Alegre (1) · Klemens Budde (1) · Medical University of South Carolina (1) · Novartis (1) · The University of Hong Kong (1) · University of California, Los Angeles (1) · University of Saskatchewan (1) · University of Utah (1)
Brazil (4) · United States (4) · Germany (2) · Canada (1) · China (1) · Taiwan (1)
Ahmed Shoker, MD (1) · Bruna Cardoso, Pharmacist (1) · Daniela Seelig, Physician (1) · Elizete Keitel, Physician (1) · Ernst Schwarz, MD (1) · Fabiano Klaus, Physician (1) · Fady M Kaldas, MD (1) · Fuad Shihab, MD (1) · Helen Zanetti, Pharmacist (1) · James Fleming, PharmD (1) · Klemens Budde, Prof Dr (1) · Larissa Pacheco, Pharmacist (1)
PMID 25988935, PMID 26398638, PMID 31769845, PMID 33988338, PMID 35230699, PMID 37525373
2009 (1)